These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8915126)

  • 21. The microfilaricidal activity of ivermectin in vitro and in vivo.
    Devaney E; Howells RE
    Tropenmed Parasitol; 1984 Mar; 35(1):47-49. PubMed ID: 6546818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
    Duke BO
    Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerance of ivermectin in human onchocerciasis.
    Aziz MA; Diallo S; Diop IM; Lariviere M; Porta M
    Lancet; 1982 Jul; 2(8291):171-3. PubMed ID: 6123884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the sensitivity of different geographical isolates of Onchocerca volvulus microfilariae to ivermectin: effects of exposure to drug on development in the blackfly Simulium ornatum.
    Tagboto SK; Townson S; Titanji VP; Awadzi K; Castro J; Zea-Flores G
    Trans R Soc Trop Med Hyg; 1994; 88(2):237-41. PubMed ID: 8036687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
    Sjoberg HT; Pionnier N; Aljayyoussi G; Metuge HM; Njouendou AJ; Chunda VC; Fombad FF; Tayong DB; Gandjui NVT; Akumtoh DN; Chounna PWN; Ndzeshang BL; Lachaud S; Tekle F; Quirynen L; Engelen M; Baeten B; Steven A; Ward SA; Taylor MJ; Wanji S; Turner JD
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006356. PubMed ID: 30650071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
    Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the real target for ivermectin resistance selection in Onchocerca volvulus?
    Grant W
    Parasitol Today; 2000 Nov; 16(11):458-9; discussion 501-2. PubMed ID: 11063850
    [No Abstract]   [Full Text] [Related]  

  • 32. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
    Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
    Pion SD; Nana-Djeunga HC; Kamgno J; Tendongfor N; Wanji S; Njiokou F; Prichard RK; Boussinesq M
    PLoS Negl Trop Dis; 2013; 7(2):e2084. PubMed ID: 23469307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
    Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
    Duke BO; Zea-Flores G; Muñoz B
    Trop Med Parasitol; 1991 Sep; 42(3):175-80. PubMed ID: 1801140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of moxidectin oral gel against Onchocerca cervicalis microfilariae.
    Monahan CM; Chapman MR; French DD; Klei TR
    J Parasitol; 1995 Feb; 81(1):117-8. PubMed ID: 7876966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
    Lariviere M; Vingtain P; Aziz M; Beauvais B; Weimann D; Derouin F; Ginoux J; Schulz-Key H; Gaxotte P; Basset D
    Lancet; 1985 Jul; 2(8448):174-7. PubMed ID: 2862370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
    Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
    Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
    Turner HC; Walker M; Attah SK; Opoku NO; Awadzi K; Kuesel AC; Basáñez MG
    Parasit Vectors; 2015 Mar; 8():167. PubMed ID: 25889256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onchocerciasis-associated morbidity: hypothesis.
    Mawson AR; WaKabongo M
    Trans R Soc Trop Med Hyg; 2002; 96(5):541-2. PubMed ID: 12474485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.